Current Events

U.S. health regulators censured Covidien Plc for failing to promptly address complaints related to deaths and serious injuries linked to its devices used in thoracic surgery.

Click here to read more.

Watchdog group Public Citizen urged U.S. regulators on Tuesday not to approve Arena Pharmaceuticals Inc's experimental diet pill lorcaserin, citing concerns it could increase patients' risk of heart valve damage.

Click here to read more.

Johnson & Johnson (JNJ) (JNJ), the biggest health-care products maker, continued to sell a vaginal mesh implant for nine months after U.S. regulators told the company to stop marketing the device, according to court records.

Click here to read more.

Metal-on-metal hip implants made by Johnson & Johnson (JNJ) and Zimmer Holding Inc. (ZMH) need more consistent testing to help lower high failure rates that lead to risky replacement surgeries, a report by regulators said.

Click here to read more.

Malpractice claims dipped dramatically among Massachusetts physicians after they began using electronic medical records, according to new research, although it's not clear whether the record-keeping was connected to the decline in claims.

Click here to read more.

Almost 16,800 adverse events associated with metal-on-metal hip implants were reported in the U.S. from 2000-2011, regulators said.

The reports almost quadrupled to 682 in 2008 from the year earlier, and rose again after a unit of Johnson & Johnson (JNJ) began recalling hip devices in 2010, according to report posted today on the Food and Drug Administration’s website. Adverse event reports in 2011 totaled 12,137 for the metal-on-metal devices, compared with 6,332 associated with other types of hip implants, according to the FDA document.

Click here to read more.

Johnson & Johnson said Friday that it would add about $600 million to its reserves to cover a possible settlement of allegations that it paid kickbacks to a company that dispenses drugs to nursing homes. Johnson & Johnson said it would take a one-time charge in the second quarter to cover a possible settlement of a whistle-blower lawsuit.

Click here to read more.

The UnitedHealth Group, one of the nation’s largest health insurers, announced Sunday night that it planned to continue offering some of the popular consumer protections required by the federal health care law, even if the Supreme Court declares the entire law unconstitutional later this month.

Click here to read more.

Johnson & Johnson’s Ethicon unit told a federal judge in West Virginia it intends to stop selling four vaginal mesh implants after being sued by more than 600 women who say the products caused internal injuries.

Click here to read more

(Reuters Health) - The U.S. Food and Drug Administration (FDA) recalls potentially harmful drugs about once every month, but they could be doing a better job of letting doctors and patients know about them, says a new study.

Click here to read more

For most of her life, Hope Rubel was a healthy woman with good medical insurance, an unblemished credit history and a solid career in graphic design. But on the day an ambulance rushed her to a Manhattan hospital emergency room shortly after her 48th birthday, she was jobless, uninsured and having a stroke. . . .